A Preliminary Study of Bone Density in Neonates

The study is to measure how dense or solid the infant's bones are using a new ultrasound machine and how that density changes over time.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Osteopenia of Prematurity Bone Diseases Bone Diseases, Metabolic Metabolic Diseases Musculoskeletal Diseases Nutritional and Metabolic Diseases

Age range

24 week–33 week

Sex eligibility

All sexes

Study type

Observational

Primary location

Tampa General Hospital/University of South Florida

Tampa, Florida, 33606, United States

About this study

premature infants weighing less than 1500 gms and less than 33 weeks gestation are eligible for the study

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

premature infants born less than 33 weeks, weighing less than 1500 gms

Exclusion criteria

congenital anomalies weight greater than 1500 gms

Treatment and study plan

ultrasound machine

Device

Weekly Bone Density measurements using the Sonometer

Other names: Omnisense 7000P Ultrasound Bone Sonometer

Primary outcomes

Develop ways to prevent and treat Osteopenia of Prematurity

Time frame: 1-2 years

Sponsors and collaborators

Lead sponsor

University of South Florida

Other

Registry information

Official study title

A Preliminary Study of Bone Density Measurements in Neonates Using the Sunlight Omnisense 7000P Ultrasound Bone Sonometer

Important dates

Study start: 2007
Primary completion: 2008
Study completion: 2008
First posted: Mar 7, 2008
Registry last updated: Jun 15, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed